HARPS GLOBAL PTE. LTD. agreed to acquire Medical business from Semperit Aktiengesellschaft Holding (WBAG:SEM) for ?115 million on December 16, 2022. The sales price of ?115 million is subject to customary price adjustment mechanisms upon completion of the transactions. The execution of the transaction is subject to the approval of the competent authorities, regulatory authorities and is expected for the second quarter of 2023. Schoenherr advised Harps Global on the deal. The Schoenherr team advising on all Austrian and Hungarian aspects of the transaction was led by both Christian Herbst (partner) and Maximilian Lang (partner). It also included Volker Weiss (partner), Kinga Hetényi (partner), Constantin Benes (partner) as well as Teresa Waidmann (counsel), Zurab Simonishvili (attorney at law), Evelin Hlina (counsel), Iliyana Sirakova (counsel), Nina Zafoschnig (attorney at law). Credit Suisse (Singapore) Ltd acted as the exclusive financial advisor to Harps Global Pte. Limited. JPMorgan Chase & Co. (NYSE:JPM) acted as financial advisor to Semperit Aktiengesellschaft Holding in the transaction. Sharon Lau and Farhana Sharmeen of acted as legal advisors to Harps Global PTE. Ltd.

HARPS GLOBAL PTE. LTD. completed the Aquisition of Medical business from Semperit Aktiengesellschaft Holding (WBAG:SEM) on August 31, 2023. All regulatory approvals received.